Jeffrey L. Wade

EVP, Gen. Counsel, Lexicon Pharmaceuticals.

Companies

Lexicon PharmaceuticalsChief operating officer Jul 8, 2024 to Jul 8, 2024¹
Lexicon PharmaceuticalsPresident Feb 11, 2022 to Jul 8, 2024²
Lexicon PharmaceuticalsChief financial officer May 19, 2010 to Feb 29, 2024³
Lexicon PharmaceuticalsGeneral counsel Feb 17, 2010 to Feb 17, 2010⁴
Lexicon PharmaceuticalsEVP, Gen. Counsel Feb 3, 2006 to Aug 14, 2009⁵

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Feb 28, 2024Shares withheld for tax 37,691 shares at $2.62 of Lexicon Pharmaceuticals⁶
Feb 28, 2024Exercised options 49,113 shares of Lexicon Pharmaceuticals⁶
Feb 28, 2024Exercised options 37,274 shares of Lexicon Pharmaceuticals⁶
Feb 28, 2024Exercised options 11,177 shares of Lexicon Pharmaceuticals⁶
Sep 14, 2023Bought 10,000 shares at $1.38 of Lexicon Pharmaceuticals⁷
Jun 20, 2023Bought 2,000 shares at $2.33 of Lexicon Pharmaceuticals⁸
Jun 20, 2023Bought 10,000 shares at $2.34 of Lexicon Pharmaceuticals⁸
Feb 28, 2023Shares withheld for tax 30,255 shares at $2.17 of Lexicon Pharmaceuticals⁹
Feb 28, 2023Exercised options 37,273 shares of Lexicon Pharmaceuticals⁹
Feb 28, 2023Exercised options 11,176 shares of Lexicon Pharmaceuticals⁹
Feb 28, 2023Exercised options 30,467 shares of Lexicon Pharmaceuticals⁹
Feb 28, 2022Shares withheld for tax 25,773 shares at $2.85 of Lexicon Pharmaceuticals¹⁰
Feb 28, 2022Exercised options 11,177 shares of Lexicon Pharmaceuticals¹⁰
Feb 28, 2022Exercised options 30,466 shares of Lexicon Pharmaceuticals¹⁰
Feb 28, 2022Exercised options 25,290 shares of Lexicon Pharmaceuticals¹⁰
Apr 14, 2021Gift 4,500 shares of Lexicon Pharmaceuticals¹¹

The numbers on this page point here. Each one links to the record it came from.